| Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes |
|
| Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies |
|
| Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease |
|
| The association of mode of location activity and mobility with acute coronary syndrome nationwide ecological study. |
|
| Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer An Application to Coronary Thrombus Aspiration. |
|
| Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin, 2003: |
|
| Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial |
|
| Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction a nationwide population-based study. |
|
| Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype a PLATO substudy. |
|
| Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis |
|
| Findings on coronary angiographies in patients with rheumatoid arthritis and ischemic heart disease are they different from patients without rheumatoid arthritis?. |
|
| Fourth universal definition of myocardial infarction (2018) |
|
| Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction |
|
| High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction |
|
| Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease insights from the SYNTAX Extended Survival study. |
|
| Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes A PLATO Sub-Study. |
|
| Income is associated with the probability to receive early coronary angiography after out-of-hospital cardiac arrest |
|
| Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology |
|
| Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force |
|
| Invasive treatment of coronary artery disease [em]Aspects on antithrombotic and percutaneous treatment options[/em]. |
|
| Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients |
|
| Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden |
|
| Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes a Swedish nationwide cohort study. |
|
| Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. |
|
| Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease |
|
| Minimum Core Data Elements for Evaluation of TAVR A Scientific Statement by PASSION CV, HVC, and TVT Registry. |
|
| A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial |
|
| N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte |
|
| Nationwide cardiovascular risk categorization applying the European Society of Cardiology (ESC) guidelines to the Swedish National Diabetes Register. |
|
| Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites |
|
| Patient experience of the informed consent process during acute myocardial infarction a sub-study of the VALIDATE-SWEDEHEART trial. |
|
| Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence |
|
| Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo |
|
| Physical Activity Reduces Epilepsy Incidence a Retrospective Cohort Study in Swedish Cross-Country Skiers and an Experimental Study in Seizure-Prone Synapsin II Knockout Mice. |
|
| Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation |
|
| Pooled analysis of adverse event collection from 4 acute coronary syndrome trials |
|
| Post-resuscitation myocardial dysfunction in out-of-hospital cardiac arrest patients randomized to immediate coronary angiography versus standard of care |
|
| Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials |
|
| Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease |
|
| Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. |
|
| Prolonged antithrombotic therapy in patients after acute coronary syndrome A critical appraisal of current European Society of Cardiology guidelines. |
|
| The publics' perspective on cardiovascular risk information Implications for practice. |
|
| Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial |
|
| A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes |
|
| Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. |
|
| Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014 |
|
| Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary |
|
| Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". |
|
| A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels |
|
| Risk of recurrent ischaemic events after myocardial infarction in long-distance ski race participants |
|
| Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention |
|
| Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis |
|
| Sex-Related Differences in Thrombus Burden in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention |
|
| Sex-specific aspects on prognosis after aortic valve replacement for aortic stenosis a SWEDEHEART registry study. |
|
| SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction a nationwide observation registry study from SWEDEHEART. |
|
| Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction A Report From the Swedish Coronary Angiography and Angioplasty Registry. |
|
| Subsequent Event Risk in Individuals With Established Coronary Heart Disease Design and Rationale of the GENIUS-CHD Consortium. |
|
| Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction A Nationwide Study. |
|
| Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease |
|
| Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial |
|
| Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial |
|
| Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack |
|
| Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy |
|
| Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes |
|
| Wytyczne ESC dotyczące postępowania w ostrym zawale serca z uniesieniem odcinka ST w 2017 roku: Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrym zawale serca z uniesieniem odcinka ST |
|
Preferred Forms
